showed that in a CCl4-induced mouse liver fibrosis model, the expression of KDM3A in HSCs was down-regulated, whereas KDM3A overexpression induced the demethylation of H3K9me2 in the PPARγ promoter, leading to inhibition of HSC activation. The gene discussed is KDM3A; the disease is Hepatic fibrosis.